Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
BMC Genomics|August 22, 2008
Diversity in genomic organisation, developmental regulation and distribution of the murine PR72/B" subunits of protein phosphatase 2AKaren Zwaenepoel, Justin V Louis, Jozef Goris, et al.
Biochemical and Biophysical Research Communications|June 27, 2009
Specific regulation of protein phosphatase 2A PR72/B'' subunits by calpainVeerle Janssens, Rita Derua, Karen Zwaenepoel, et al.
Oncotarget|June 9, 2022
Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)?Birgitta Hiddinga, Karen Zwaenepoel, Annelies Janssens, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 15, 2009
Protein phosphatase 2A PR130/B''alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signalingKaren Zwaenepoel, Jozef Goris, Christophe Erneux, et al.
Histopathology|March 14, 2014
Detection of ALK expression in non-small-cell lung cancer with ALK gene rearrangements--comparison of multiple immunohistochemical methodsKaren Zwaenepoel, Amber Van Dongen, Suzan Lambin, et al.
The Journal of Biological Chemistry|July 20, 2007
Selection of protein phosphatase 2A regulatory subunits is mediated by the C terminus of the catalytic SubunitSari Longin, Karen Zwaenepoel, Justin V Louis, et al.
The Journal of Molecular Diagnostics : JMD|November 21, 2016
A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in PlasmaLaure Sorber, Karen Zwaenepoel, Vanessa Deschoolmeester, et al.
Journal of Cell Science|March 6, 2016
PP2A binds to the LIM domains of lipoma-preferred partner through its PR130/B″ subunit to regulate cell adhesion and migrationVeerle Janssens, Karen Zwaenepoel, Carine Rossé, et al.
Immunotherapy|September 4, 2023
PD-1, PD-L1, IDO, CD70 and microsatellite instability as potential targets to prevent immune evasion in sarcomasVasiliki Siozopoulou, Evelien Smits, Karen Zwaenepoel, et al.
Cancers|January 22, 2021
Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel?Vasiliki Siozopoulou, Andreas Domen, Karen Zwaenepoel, et al.
Pageof 7